TABLE 3.
Post-ACZ CBF (ml/100 g/min) |
|||||||
---|---|---|---|---|---|---|---|
Baseline CBF (ml/100 g/min) | (CVR(%)) | ||||||
ACA | MCA | PCA | ACA | MCA | PCA | ||
HC | 48.8 ± 7.7 | 51.5 ± 8.1 | 50.2 ± 6.4 | 75.8 ± 12.2 | 80.6 ± 13.7 | 78.7 ± 13.3 | |
(56.6 ± 23.0) | (57.5 ± 23.1) | (57.5 ± 23.6) | |||||
MM | Normal | 47.6 ± 9.0 | 49.3 ± 8.9 | 45.4 ± 7.9 | 73.8 ± 15.7 | 79.7 ± 18.1 | 70.7 ± 12.6 |
(54.6 ± 14.6) | (61.0 ± 17.8) | (56.4 ± 13.6) | |||||
Mild/moderate | 40.7 ± 6.4 | 44.5 ± 8.0 | 41.3 ± 1.1 | 58.4 ± 12.7 | 65.7 ± 13.4 | 68.2 ± 4.6 | |
(43.6 ± 18.3) | (47.9 ± 16.4) | (65.0 ± 6.7) | |||||
Severe/occluded | 38.0 ± 4.8 | 40.9 ± 5.5 | — | 54.3 ± 6.2 | 56.1 ± 3.9 | — | |
(43.8 ± 17.5) | (38.9 ± 15.0) | ||||||
Total | 42.2 ± 8.1 | 45.0 ± 8.4 | 45.1 ± 7.9 | 62.2 ± 15.1 | 67.3 ± 16.2 | 70.7 ± 12.6 | |
(47.1 ± 18.1) | (49.4 ± 18.8) | (57.2 ± 13.5) |